Cancer Activity and Lifestyle Measurement Study

Running, not enrolling

Conditions studied: Breast Cancer

In brief

The CALM Study is an observational study to investigate the associations of linoleic acid levels in the blood, diet, activity, and lifestyle factors with measures of muscle strength, muscle function and overall outcomes for postmenopausal breast cancer patients treated with anthracycline chemotherapy.

Key facts

Study ID

NCT03961685

Run by

Ohio State University

People needed

14

Starts

2019-01-04

Expected to finish

2026-12-01

Last updated by the study team

2026-04-21

Who can join

Age: 25 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of stage I-II breast cancer, adjuvant or neoadjuvant anthracycline therapy

You may not qualify if…

• current smoker, under medical supervision for any other type of cancer, prior history of malignancies, infection requiring antibiotics in the last 3 months, diagnosis of hear disease or previous heart attach, stroke, or heart surgery, pacemaker or defibrillator, cardiac edema, autoimmune or inflammatory disease, current use of hormone replacement therapy, liver diseases, kidney diseases or failure, digestive diseases, pulmonary diseases or edema, diabetes, severe claustrophobia and/or metal implants preventing MRI measurement, orthopedic diagnoses prevent mobility, mitochondrial diseases, any other condition that would impede or be contraindicated for study assessments

Where it is running

• The Ohio State University Clinical Research Center (Davis Medical Research Center) — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.